Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1897-4287
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy ; volume:17 ; number:1 ; day:14 ; month:3 ; year:2019 ; pages:1-5 ; date:12.2019
Hereditary cancer in clinical practice ; 17, Heft 1 (14.3.2019), 1-5, 12.2019
- Urheber
-
Menkiszak, Janusz
Chudecka-Głaz, Anita
Cymbaluk-Płoska, Aneta
Celewicz, Aleksander
Kojs, Zbigniew
Szajda, Mariusz
Świniarska, Maria
Bedner, Ryszard
Jurczak, Anna
Celewicz, Marta
Cieszyńska, Monika
Lubiński, Jan
Gronwald, Jacek
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13053-019-0109-5
- URN
-
urn:nbn:de:101:1-2019040716352403122138
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Menkiszak, Janusz
- Chudecka-Głaz, Anita
- Cymbaluk-Płoska, Aneta
- Celewicz, Aleksander
- Kojs, Zbigniew
- Szajda, Mariusz
- Świniarska, Maria
- Bedner, Ryszard
- Jurczak, Anna
- Celewicz, Marta
- Cieszyńska, Monika
- Lubiński, Jan
- Gronwald, Jacek
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features
Intra Peritoneal Chemotherapy in Epithelial Ovarian Cancers
Cisplatin in breast cancer treatment in BRCA1 carriers
Folic acid and cancer risk in BRCA1 carriers
Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers
Cytotoxic and targeted therapy for BRCA1/2-driven cancers
Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers
Peritoneal dissemination of breast cancer diagnosed by laparoscopy
Survival in Norwegian BRCA1 mutation carriers with breast cancer
Selenium and the risk of cancer in BRCA1 carriers
Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features
Intra Peritoneal Chemotherapy in Epithelial Ovarian Cancers
Cisplatin in breast cancer treatment in BRCA1 carriers
Folic acid and cancer risk in BRCA1 carriers
Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers
Cytotoxic and targeted therapy for BRCA1/2-driven cancers
Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers
Peritoneal dissemination of breast cancer diagnosed by laparoscopy
Survival in Norwegian BRCA1 mutation carriers with breast cancer
Selenium and the risk of cancer in BRCA1 carriers
Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features
Intra Peritoneal Chemotherapy in Epithelial Ovarian Cancers
Cisplatin in breast cancer treatment in BRCA1 carriers
Folic acid and cancer risk in BRCA1 carriers
Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers
Cytotoxic and targeted therapy for BRCA1/2-driven cancers
Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic sequence variant carriers: a single institution experience
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers
Peritoneal dissemination of breast cancer diagnosed by laparoscopy
Survival in Norwegian BRCA1 mutation carriers with breast cancer